Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

172.32
+6.543.94%
Post-market: 172.320.00000.00%17:12 EDT
Volume:744.24K
Turnover:127.34M
Market Cap:8.48B
PE:-59.17
High:172.66
Open:164.77
Low:164.77
Close:165.78
52wk High:228.88
52wk Low:113.89
Shares:49.22M
Float Shares:48.62M
Volume Ratio:1.13
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9122
EPS(LYR):-2.9122
ROE:-4.23%
ROA:4.24%
PB:2.68
PE(LYR):-59.17

Loading ...

Earning Preview: Charles River Laboratories this quarter’s revenue is expected to increase by 3.77%, and institutional views are broadly bullish

Earnings Agent
·
Apr 30

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
5 hours ago

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Apr 30

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 29

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 25

Charles River Laboratories International Inc. Stock Slides 9.2%, Underperforms Peers

Dow Jones
·
Apr 24

AbbVie receives CRL from FDA regarding BLA for trenibotulinumtoxinE

TIPRANKS
·
Apr 24

Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104

GlobeNewswire
·
Apr 24

Revvity Falls 15.5%, Bio-Techne Drops 10.1%, IQVIA Drops 8.3%, Charles River Down 7%

THOMSON REUTERS
·
Apr 23

Shares of Biotech and Medical Equipment Cos Fall After Thermo Fisher Results, Outlook

THOMSON REUTERS
·
Apr 23

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 22

Charles River reports results of restrospective analysis on VCGs in toxicology

TIPRANKS
·
Apr 21

Charles River analysis finds virtual control groups match NOAEL outcomes in toxicology studies

Reuters
·
Apr 21

Is Cheaper Energy and Shipping Altering The Investment Case For Charles River Laboratories (CRL)?

Simply Wall St.
·
Apr 20

GPT-Rosalind Sparks CRO Sector Slump: Should Investors Buy the Dip or Exit Amid AI Drug R&D Impact?

TradingKey
·
Apr 17

Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Apr 17

Charles River Labs sets first-quarter earnings release, conference call

Reuters
·
Apr 16

Charles River Labs : Barclays Raises Target Price to $210 From $200

THOMSON REUTERS
·
Apr 15

Charles River Labs Is Maintained at Overweight by Barclays

Dow Jones
·
Apr 15

Charles River Laboratories Positioned as 'Leading' CRO as Preclinical R&D Inflection Nears, RBC Says

MT Newswires Live
·
Apr 14